Synopsis
In one case of untreated Hashimoto's thyroiditis, the serum thyroxine (T4) value, obtained by radioimmunoassay (RIA) employing resin to separate bound and free T4, was significantly lower than that obtained by competitive protein binding analysis (CPBA). The discrepancy was found to be due to the presence of anti-thyroxine autoantibody in the serum. This phenomenon is considered to be of practical importance in interpreting the T4 value by RIA in cases with autoimmune thyroid diseases.
The binding of serum thyroxine (T4) to gammaglobulin has been reported in patients with thyroid cancer (Robbins et al., 1956 ) and Hashimoto's thyroiditis (Premachandra and Blumenthal, 1967; Ochi et al., 1972) .
Recently Staeheli et al.(1975) demonstrated the presence of and-T4 and anti-triiodothyronine (T3) antibodies in different thyroid conditions by disrupting the antigen-antibody complex, and predicted the possibility of spuriously high or low serum T4 and T3 values by radioimmunoassay (RIA) due to these antibodies.
In fact, one case of euthyroid Graves' disease with ophthalmopathy has been reported to have undetectable T3 by RIA, while large amounts of T3 could be detected from an ethanol extract of the serum (Sterling et al., 1973) . In addition, a patient with abnormal T3-binding immunoglobulins has also been described (Wu and Green, 1976) . In this case, using a single-antibody technique, serum T3 (RIA) was reported as being indeterminate due to this abnormal T3-binding protein.
However, when a double-antibody method was used a high T3 value was obtained.
We have recently studied a patient with Hashimoto's thyroiditis whose serum T4 value measured by a single-antibody RIA was much lower than that measured by competitive protein binding analysis (CPBA). It is suggested that this discrepancy is caused by the presence of the anti-T4 autoantibody in the serum. Fig. 2 compares the elution patterns from a Sephadex G-200 column of 125I-T4 added to heat-treated patient's and normal control sera. Only with the patient's serum was an early radioactive peak observed in the area where the 7S protein fraction was eluted. The binding of 125I-T4 to the 7S and IgG fractions determined by the PEG method were 34.0% and 51.0%, respectively, whereas binding to the 19S fraction was negligible (Table 2) . By using the double antibody method, the binding of 125I-T4 to the patient's serum and its IgG fraction were 15.4 and 9.0%, respectively, while Table 1 . Binding of 225I-T4 to the serum detected by using the T4 RI A and RIA-Mat T4 systems without anti-T4 serum.
125I-T4 binding to the and-T4 rabbit serum of each kit was shown for comparison. % bound with Table 2 . Binding of 125I-T4 to the serum and its fractions detected by precipitation at 12.5% PEG. Specificity of the T4 binding. Fig. 3 shows the dose-dependent displacement of binding of '25I-T4 to the patient's IgG by the addition of unlabeled T4. The assay was performed by PEG method. The cross reaction with T3 was approximately 8.3%. MIT and DIT did not displace the labeled T4 when tested in amounts varying from 0.1 to 100 ng per assay. No binding to the serum of other radioactive peptide hormones such as TSH, HGH or insulin could be detected. suggested by Staeheli et al.(1975) , the patients in the present study had received no treatment for 10 years.
Her serum anti-Tg, ,which had been positive 10 years ago was negative at the time of the present study. Staeheli et al.(1975) have also reported cases with anti-T4 antibodies without anti-Tg. Further accumulation of case studiesis required for the understanding of these antibodies.
The existence of such a case should be kept in mind to avoid possible erroneous clinical interpretation of the T4 value by RIA. As was shown by Wu and Green (1976) for T3, if the double antibody method is used for the assay, the value would be high in this case. T4 assay after extraction should be performed when the data on unextracted serum are discordant with the clinical state, especially in cases with autoimmune thyroid diseases.
